Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)
Turkey
· Delayed Price · Currency is TRY 288.00
-13.75 (-4.56%)
At close: Apr 28, 2026
IST:ONCSM Cash Flow Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 50.39 | -77.45 | -115.23 | -20.76 | 71.73 |
| Depreciation & Amortization | 55.34 | 62.95 | 52.94 | 36.45 | 8 |
| Other Amortization | 3.78 | 5.38 | 3.44 | 2.86 | - |
| Loss (Gain) From Sale of Assets | 0.42 | 0.04 | - | - | - |
| Provision & Write-off of Bad Debts | 0.19 | - | 15.79 | 2.24 | 0.56 |
| Other Operating Activities | 64.16 | 88.87 | 30.11 | -11.12 | 8.73 |
| Change in Accounts Receivable | -155.74 | -9.29 | 0.62 | 21.17 | -13.09 |
| Change in Inventory | 28.84 | 37.65 | 15.13 | 6.97 | -27.96 |
| Change in Accounts Payable | 21.39 | -14.51 | -12.86 | -3.86 | 4.65 |
| Change in Other Net Operating Assets | 0.59 | 18.46 | -26.87 | 18.75 | -0.89 |
| Operating Cash Flow | 69.36 | 112.12 | -36.92 | 52.69 | 51.73 |
| Operating Cash Flow Growth | -38.14% | - | - | 1.86% | - |
| Capital Expenditures | -60.92 | -28.55 | -45.58 | -26.02 | -10.96 |
| Sale of Property, Plant & Equipment | - | 0.37 | 15.07 | - | - |
| Cash Acquisitions | - | - | - | - | -24.35 |
| Sale (Purchase) of Intangibles | -5.68 | -2.54 | - | - | -1.68 |
| Investment in Securities | 0.01 | -0.97 | -1.16 | -1.05 | - |
| Other Investing Activities | 0.94 | - | - | - | -0.8 |
| Investing Cash Flow | -65.66 | -31.69 | -31.67 | -27.07 | -37.79 |
| Long-Term Debt Issued | 28.55 | - | 59.32 | - | 0.35 |
| Short-Term Debt Repaid | - | - | - | - | -5.95 |
| Long-Term Debt Repaid | - | -55.78 | -1.92 | -12.79 | -8.68 |
| Total Debt Repaid | - | -55.78 | -1.92 | -12.79 | -14.64 |
| Net Debt Issued (Repaid) | 28.55 | -55.78 | 57.4 | -12.79 | -14.29 |
| Issuance of Common Stock | - | - | 147.28 | - | - |
| Common Dividends Paid | - | - | -19.91 | - | - |
| Other Financing Activities | -32.25 | -45.31 | -13.83 | -1.47 | -2.31 |
| Financing Cash Flow | -3.7 | -101.09 | 170.94 | -14.26 | -16.59 |
| Miscellaneous Cash Flow Adjustments | -13.08 | -31.51 | -45.62 | -7.73 | - |
| Net Cash Flow | -13.08 | -52.18 | 56.73 | 3.63 | -2.65 |
| Free Cash Flow | 8.44 | 83.57 | -82.5 | 26.67 | 40.76 |
| Free Cash Flow Growth | -89.90% | - | - | -34.58% | - |
| Free Cash Flow Margin | 1.19% | 17.05% | -23.76% | 9.10% | 31.85% |
| Free Cash Flow Per Share | 0.35 | 3.50 | -3.46 | 2.20 | 172.23 |
| Cash Interest Paid | 32.25 | 45.31 | 13.83 | 1.47 | 2.31 |
| Cash Income Tax Paid | -4.81 | -0.48 | 4 | 5 | -4.65 |
| Levered Free Cash Flow | -29.37 | -14.56 | -103.47 | -25.2 | - |
| Unlevered Free Cash Flow | -9.21 | 13.94 | -94.56 | -23.93 | - |
| Change in Working Capital | -104.93 | 32.32 | -23.98 | 43.02 | -37.3 |
Source: S&P Capital IQ. Standard template. Financial Sources.